James (Jim) Bolognese

Senior Research Advisor, Statistics & Computer Science

Jim is a highly experienced biostatistician with an impressive career spanning over 4 decades. Before joining Cytel, he spent 33 years at Merck, where he played a crucial role as a biostatistician in all phases of ​drug development across various ​therapeutic areas.

In the last 15 years at Cytel, Jim has served as a biostatistical consultant to biotech companies, providing strategic insights into drug development challenges. Additionally, he has contributed significantly to biostatistical software development, offering a unique end-user perspective.

Jim has a BS in Mathematics from Bucknell University and a Masters in Statistics from the University of Florida.

James (Jim) Bolognese

Related Articles

Subpopulations in Clinical Trial Design: Thinking Through Hypothesis Testing
Blog
June 11, 2024
Subpopulations in Clinical Trial Design: Thinking Through Hypothesis Testing
Read More
Negative Binomial Distribution in Group Sequential Designs
Blog
February 20, 2024
Negative Binomial Distribution in Group Sequential Designs
Read More